Global Nuclear Medicine/Radiopharmaceuticals Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
Summary
Market Overview
The global Nuclear Medicine/Radiopharmaceuticals market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 7.8% in the forecast period of 2020 to 2025 and will expected to reach USD 7558.2 million by 2025, from USD 5593 million in 2019.
The Nuclear Medicine/Radiopharmaceuticals market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Nuclear Medicine/Radiopharmaceuticals market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Nuclear Medicine/Radiopharmaceuticals market has been segmented into Diagnostic, Therapeutic, etc.
By Application, Nuclear Medicine/Radiopharmaceuticals has been segmented into Oncology, Thyroid, Cardiology, etc.
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Nuclear Medicine/Radiopharmaceuticals market presented in the report. This section sheds light on the sales growth of different regional and country-level Nuclear Medicine/Radiopharmaceuticals markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Nuclear Medicine/Radiopharmaceuticals market.
The report offers in-depth assessment of the growth and other aspects of the Nuclear Medicine/Radiopharmaceuticals market in important countries (regions), including United States, Canada, Mexico, Germany, France, United Kingdom, Russia, Italy, China, Japan, Korea, India, Southeast Asia, Australia, Brazil and Saudi Arabia, etc. It also throws light on the progress of key regional Nuclear Medicine/Radiopharmaceuticals markets such as North America, Europe, Asia-Pacific, South America and Middle East & Africa.
Competitive Landscape and Nuclear Medicine/Radiopharmaceuticals Market Share Analysis
Nuclear Medicine/Radiopharmaceuticals competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Nuclear Medicine/Radiopharmaceuticals sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Nuclear Medicine/Radiopharmaceuticals sales, revenue and market share for each player covered in this report.
The major players covered in Nuclear Medicine/Radiopharmaceuticals are: China Isotope & Radiation, Ciaeriar, Dongcheng, Jaco, Shanghai Atom Kexing, Advanced Molecular-imaging Solution, etc. Among other players domestic and global, Nuclear Medicine/Radiopharmaceuticals market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Nuclear Medicine/Radiopharmaceuticals product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Nuclear Medicine/Radiopharmaceuticals, with price, sales, revenue and global market share of Nuclear Medicine/Radiopharmaceuticals in 2018 and 2019.
Chapter 3, the Nuclear Medicine/Radiopharmaceuticals competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Nuclear Medicine/Radiopharmaceuticals breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Nuclear Medicine/Radiopharmaceuticals market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Nuclear Medicine/Radiopharmaceuticals sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Nuclear Medicine/Radiopharmaceuticals Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Nuclear Medicine/Radiopharmaceuticals Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Diagnostic
1.2.3 Therapeutic
1.3 Market Analysis by Application
1.3.1 Overview: Global Nuclear Medicine/Radiopharmaceuticals Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Oncology
1.3.3 Thyroid
1.3.4 Cardiology
1.4 Overview of Global Nuclear Medicine/Radiopharmaceuticals Market
1.4.1 Global Nuclear Medicine/Radiopharmaceuticals Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 China Isotope & Radiation
2.1.1 China Isotope & Radiation Details
2.1.2 China Isotope & Radiation Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 China Isotope & Radiation SWOT Analysis
2.1.4 China Isotope & Radiation Product and Services
2.1.5 China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Ciaeriar
2.2.1 Ciaeriar Details
2.2.2 Ciaeriar Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Ciaeriar SWOT Analysis
2.2.4 Ciaeriar Product and Services
2.2.5 Ciaeriar Nuclear Medicine/Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Dongcheng
2.3.1 Dongcheng Details
2.3.2 Dongcheng Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Dongcheng SWOT Analysis
2.3.4 Dongcheng Product and Services
2.3.5 Dongcheng Nuclear Medicine/Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Jaco
2.4.1 Jaco Details
2.4.2 Jaco Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Jaco SWOT Analysis
2.4.4 Jaco Product and Services
2.4.5 Jaco Nuclear Medicine/Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Shanghai Atom Kexing
2.5.1 Shanghai Atom Kexing Details
2.5.2 Shanghai Atom Kexing Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Shanghai Atom Kexing SWOT Analysis
2.5.4 Shanghai Atom Kexing Product and Services
2.5.5 Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Advanced Molecular-imaging Solution
2.6.1 Advanced Molecular-imaging Solution Details
2.6.2 Advanced Molecular-imaging Solution Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Advanced Molecular-imaging Solution SWOT Analysis
2.6.4 Advanced Molecular-imaging Solution Product and Services
2.6.5 Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Nuclear Medicine/Radiopharmaceuticals Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Nuclear Medicine/Radiopharmaceuticals Manufacturer Market Share in 2019
3.3.2 Top 6 Nuclear Medicine/Radiopharmaceuticals Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Nuclear Medicine/Radiopharmaceuticals Sales, Revenue and Market Share by Regions
4.1.1 Global Nuclear Medicine/Radiopharmaceuticals Sales and Market Share by Regions (2015-2020)
4.1.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue and Market Share by Regions (2015-2020)
4.2 North America Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2015-2020)
4.3 Europe Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2015-2020)
4.5 South America Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Nuclear Medicine/Radiopharmaceuticals Sales, Revenue and Market Share by Country
5.1.1 North America Nuclear Medicine/Radiopharmaceuticals Sales and Market Share by Country (2015-2020)
5.1.2 North America Nuclear Medicine/Radiopharmaceuticals Revenue and Market Share by Country (2015-2020)
5.2 United States Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2015-2020)
5.3 Canada Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2015-2020)
5.4 Mexico Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Nuclear Medicine/Radiopharmaceuticals Sales, Revenue and Market Share by Country
6.1.1 Europe Nuclear Medicine/Radiopharmaceuticals Sales and Market Share by Country (2015-2020)
6.1.2 Europe Nuclear Medicine/Radiopharmaceuticals Revenue and Market Share by Country (2015-2020)
6.2 Germany Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2015-2020)
6.3 UK Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2015-2020)
6.4 France Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2015-2020)
6.5 Russia Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2015-2020)
6.6 Italy Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Revenue and Market Share by Regions (2015-2020)
7.2 China Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2015-2020)
7.3 Japan Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2015-2020)
7.4 Korea Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2015-2020)
7.5 India Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2015-2020)
7.7 Australia Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Nuclear Medicine/Radiopharmaceuticals Sales, Revenue and Market Share by Country
8.1.1 South America Nuclear Medicine/Radiopharmaceuticals Sales and Market Share by Country (2015-2020)
8.1.2 South America Nuclear Medicine/Radiopharmaceuticals Revenue and Market Share by Country (2015-2020)
8.2 Brazil Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2015-2020)
8.3 Argentina Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2015-2020)
9.3 Turkey Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2015-2020)
9.4 Egypt Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2015-2020)
9.5 South Africa Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Nuclear Medicine/Radiopharmaceuticals Sales and Market Share by Type (2015-2020)
10.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue and Market Share by Type (2015-2020)
10.3 Global Nuclear Medicine/Radiopharmaceuticals Price by Type (2015-2020)
11 Global Nuclear Medicine/Radiopharmaceuticals Market Segment by Application
11.1 Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application (2015-2020)
11.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Application (2015-2020)
11.3 Global Nuclear Medicine/Radiopharmaceuticals Price by Application (2015-2020)
12 Market Forecast
12.1 Global Nuclear Medicine/Radiopharmaceuticals Sales, Revenue and Growth Rate (2021-2025)
12.2 Nuclear Medicine/Radiopharmaceuticals Market Forecast by Regions (2021-2025)
12.2.1 North America Nuclear Medicine/Radiopharmaceuticals Market Forecast (2021-2025)
12.2.2 Europe Nuclear Medicine/Radiopharmaceuticals Market Forecast (2021-2025)
12.2.3 Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Market Forecast (2021-2025)
12.2.4 South America Nuclear Medicine/Radiopharmaceuticals Market Forecast (2021-2025)
12.2.5 Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Market Forecast (2021-2025)
12.3 Nuclear Medicine/Radiopharmaceuticals Market Forecast by Type (2021-2025)
12.3.1 Global Nuclear Medicine/Radiopharmaceuticals Sales Forecast by Type (2021-2025)
12.3.2 Global Nuclear Medicine/Radiopharmaceuticals Market Share Forecast by Type (2021-2025)
12.4 Nuclear Medicine/Radiopharmaceuticals Market Forecast by Application (2021-2025)
12.4.1 Global Nuclear Medicine/Radiopharmaceuticals Sales Forecast by Application (2021-2025)
12.4.2 Global Nuclear Medicine/Radiopharmaceuticals Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Tables and Figures
List of Tables
Table 1. Global Nuclear Medicine/Radiopharmaceuticals Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Nuclear Medicine/Radiopharmaceuticals by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Nuclear Medicine/Radiopharmaceuticals Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. China Isotope & Radiation Basic Information, Manufacturing Base and Competitors
Table 8. China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Major Business
Table 9. China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Total Revenue (USD Million) (2017-2018)
Table 10. China Isotope & Radiation SWOT Analysis
Table 11. China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Product and Services
Table 12. China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Ciaeriar Basic Information, Manufacturing Base and Competitors
Table 14. Ciaeriar Nuclear Medicine/Radiopharmaceuticals Major Business
Table 15. Ciaeriar Nuclear Medicine/Radiopharmaceuticals Total Revenue (USD Million) (2017-2018)
Table 16. Ciaeriar SWOT Analysis
Table 17. Ciaeriar Nuclear Medicine/Radiopharmaceuticals Product and Services
Table 18. Ciaeriar Nuclear Medicine/Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Dongcheng Basic Information, Manufacturing Base and Competitors
Table 20. Dongcheng Nuclear Medicine/Radiopharmaceuticals Major Business
Table 21. Dongcheng Nuclear Medicine/Radiopharmaceuticals Total Revenue (USD Million) (2017-2018)
Table 22. Dongcheng SWOT Analysis
Table 23. Dongcheng Nuclear Medicine/Radiopharmaceuticals Product and Services
Table 24. Dongcheng Nuclear Medicine/Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Jaco Basic Information, Manufacturing Base and Competitors
Table 26. Jaco Nuclear Medicine/Radiopharmaceuticals Major Business
Table 27. Jaco Nuclear Medicine/Radiopharmaceuticals Total Revenue (USD Million) (2017-2018)
Table 28. Jaco SWOT Analysis
Table 29. Jaco Nuclear Medicine/Radiopharmaceuticals Product and Services
Table 30. Jaco Nuclear Medicine/Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Shanghai Atom Kexing Basic Information, Manufacturing Base and Competitors
Table 32. Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Major Business
Table 33. Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Total Revenue (USD Million) (2017-2018)
Table 34. Shanghai Atom Kexing SWOT Analysis
Table 35. Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Product and Services
Table 36. Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Advanced Molecular-imaging Solution Basic Information, Manufacturing Base and Competitors
Table 38. Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Major Business
Table 39. Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Total Revenue (USD Million) (2017-2018)
Table 40. Advanced Molecular-imaging Solution SWOT Analysis
Table 41. Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Product and Services
Table 42. Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Global Nuclear Medicine/Radiopharmaceuticals Sales by Manufacturer (2018-2019) (K Units)
Table 44. Global Nuclear Medicine/Radiopharmaceuticals Revenue by Manufacturer (2018-2019) (USD Million)
Table 45. Global Nuclear Medicine/Radiopharmaceuticals Sales by Regions (2015-2020) (K Units)
Table 46. Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Regions (2015-2020)
Table 47. Global Nuclear Medicine/Radiopharmaceuticals Revenue by Regions (2015-2020) (USD Million)
Table 48. North America Nuclear Medicine/Radiopharmaceuticals Sales by Countries (2015-2020) (K Units)
Table 49. North America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Countries (2015-2020)
Table 50. North America Nuclear Medicine/Radiopharmaceuticals Revenue by Countries (2015-2020) (USD Million)
Table 51. North America Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Countries (2015-2020)
Table 52. Europe Nuclear Medicine/Radiopharmaceuticals Sales by Countries (2015-2020) (K Units)
Table 53. Europe Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Countries (2015-2020)
Table 54. Europe Nuclear Medicine/Radiopharmaceuticals Revenue by Countries (2015-2020) (USD Million)
Table 55. Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Sales by Regions (2015-2020) (K Units)
Table 56. Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Regions (2015-2020)
Table 57. Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Revenue by Regions (2015-2020) (USD Million)
Table 58. South America Nuclear Medicine/Radiopharmaceuticals Sales by Countries (2015-2020) (K Units)
Table 59. South America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Countries (2015-2020)
Table 60. South America Nuclear Medicine/Radiopharmaceuticals Revenue by Countries (2015-2020) (USD Million)
Table 61. South America Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Countries (2015-2020)
Table 62. Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Sales by Countries (2015-2020) (K Units)
Table 63. Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Countries (2015-2020)
Table 64. Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Revenue by Countries (2015-2020) (USD Million)
Table 65. Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Countries (2015-2020)
Table 66. Global Nuclear Medicine/Radiopharmaceuticals Sales by Type (2015-2020) (K Units)
Table 67. Global Nuclear Medicine/Radiopharmaceuticals Sales Share by Type (2015-2020)
Table 68. Global Nuclear Medicine/Radiopharmaceuticals Revenue by Type (2015-2020) (USD Million)
Table 69. Global Nuclear Medicine/Radiopharmaceuticals Revenue Share by Type (2015-2020)
Table 70. Global Nuclear Medicine/Radiopharmaceuticals Sales by Application (2015-2020) (K Units)
Table 71. Global Nuclear Medicine/Radiopharmaceuticals Sales Share by Application (2015-2020)
Table 72. Global Nuclear Medicine/Radiopharmaceuticals Sales Forecast by Regions (2021-2025) (K Units)
Table 73. Global Nuclear Medicine/Radiopharmaceuticals Market Share Forecast by Regions (2021-2025)
Table 74. Global Nuclear Medicine/Radiopharmaceuticals Sales Forecast by Type (2021-2025) (K Units)
Table 75. Global Nuclear Medicine/Radiopharmaceuticals Market Share Forecast by Type (2021-2025)
Table 76. Global Nuclear Medicine/Radiopharmaceuticals Sales Forecast by Application (2021-2025)
Table 77. Global Nuclear Medicine/Radiopharmaceuticals Market Share Forecast by Application (2021-2025)
Table 78. Direct Channel Pros & Cons
Table 79. Indirect Channel Pros & Cons
Table 80. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Nuclear Medicine/Radiopharmaceuticals Picture
Figure 2. Global Sales Market Share of Nuclear Medicine/Radiopharmaceuticals by Type in 2019
Figure 3. Diagnostic Picture
Figure 4. Therapeutic Picture
Figure 5. Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application in 2018
Figure 6. Oncology Picture
Figure 7. Thyroid Picture
Figure 8. Cardiology Picture
Figure 9. Global Nuclear Medicine/Radiopharmaceuticals Market Status and Outlook (2015-2025) (USD Million)
Figure 10. United States Nuclear Medicine/Radiopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Canada Nuclear Medicine/Radiopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Mexico Nuclear Medicine/Radiopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Germany Nuclear Medicine/Radiopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 14. France Nuclear Medicine/Radiopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 15. UK Nuclear Medicine/Radiopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Russia Nuclear Medicine/Radiopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Italy Nuclear Medicine/Radiopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 18. China Nuclear Medicine/Radiopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Japan Nuclear Medicine/Radiopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Korea Nuclear Medicine/Radiopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 21. India Nuclear Medicine/Radiopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Southeast Asia Nuclear Medicine/Radiopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Australia Nuclear Medicine/Radiopharmaceuticals Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 24. Brazil Nuclear Medicine/Radiopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Egypt Nuclear Medicine/Radiopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Saudi Arabia Nuclear Medicine/Radiopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 27. South Africa Nuclear Medicine/Radiopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Turkey Nuclear Medicine/Radiopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Manufacturer in 2019
Figure 30. Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Manufacturer in 2019
Figure 31. Top 3 Nuclear Medicine/Radiopharmaceuticals Manufacturer (Revenue) Market Share in 2019
Figure 32. Top 6 Nuclear Medicine/Radiopharmaceuticals Manufacturer (Revenue) Market Share in 2019
Figure 33. Key Manufacturer Market Share Trend
Figure 34. Global Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2015-2020) (K Units)
Figure 35. Global Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2015-2020) (USD Million)
Figure 36. Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Regions (2015-2020)
Figure 37. Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Regions in 2018
Figure 38. North America Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure 39. Europe Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure 41. South America Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure 42. Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure 43. North America Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2015-2020) (USD Million)
Figure 44. North America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Countries (2015-2020)
Figure 45. North America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Countries in 2018
Figure 46. North America Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 47. North America Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Countries in 2018
Figure 48. United States Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2015-2020) (K Units)
Figure 49. Canada Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Mexico Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Europe Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2015-2020) (USD Million)
Figure 52. Europe Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Countries (2015-2020)
Figure 53. Europe Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Countries in 2019
Figure 54. Germany Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2015-2020) (K Units)
Figure 55. UK Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2015-2020) (K Units)
Figure 56. France Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Russia Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Italy Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2015-2020) (USD Million)
Figure 60. Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Regions 2019
Figure 61. Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Regions 2019
Figure 62. China Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Japan Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Korea Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2015-2020) (K Units)
Figure 65. India Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Southeast Asia Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2015-2020) (K Units)
Figure 67. South America Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2015-2020) (USD Million)
Figure 68. South America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Countries in 2019
Figure 69. South America Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Countries in 2019
Figure 70. Brazil Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Argentina Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2015-2020) (K Units)
Figure 72. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Countries in 2019
Figure 74. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Countries (2015-2020)
Figure 75. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Countries in 2019
Figure 76. Saudi Arabia Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Egypt Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Turkey Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2015-2020) (K Units)
Figure 79. South Africa Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Global Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2021-2025) (K Units)
Figure 81. Global Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2021-2025) (USD Million)
Figure 82. North America Sales Nuclear Medicine/Radiopharmaceuticals Market Forecast (2021-2025) (K Units)
Figure 83. Europe Sales Nuclear Medicine/Radiopharmaceuticals Market Forecast (2021-2025) (K Units)
Figure 84. Asia-Pacific Sales Nuclear Medicine/Radiopharmaceuticals Market Forecast (2021-2025) (K Units)
Figure 85. South America Sales Nuclear Medicine/Radiopharmaceuticals Market Forecast (2021-2025) (K Units)
Figure 86. Middle East & Africa Sales Nuclear Medicine/Radiopharmaceuticals Market Forecast (2021-2025) (K Units)
Figure 87. Sales Channel: Direct Channel vs Indirect Channel
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets